Cite
MLA Citation
Jedd D. Wolchok et al.. “Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma.” Journal of clinical oncology, vol. 40, no. 2, 2022, pp. 127–137. http://access.bl.uk/ark:/81055/vdc_100150609950.0x000026